ConductScience.org, home

Paper25058905

Cisplatin in cancer therapy: molecular mechanisms of action.

Dasari S and 1 other. Eur J Pharmacol, 2014. Cited by 3,949 papers, by iCite.

Cite this record

ConductScience Library. Cisplatin in cancer therapy: molecular mechanisms of action. Papers, record 25058905. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25058905

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cisplatin in cancer therapy: molecular mechanisms of action.
PubMed
Journal
Eur J Pharmacol
PubMed
Year
2014
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Review
PubMed
Citations, by iCite
3,949
iCite
Relative citation ratio, by iCite
142
iCite
Revised in PubMed
2024-03-31
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dasari SShaloam
2Tchounwou PBPaul Bernard

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
CisplatinMajor topic
NeoplasmsMajor topic
Animals
Drug Therapy, Combination
Humans

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
G12 MD007581NIMHD NIH HHSUnited StatesG12MD007581PubMed and NIH
G12MD007581NIMHD NIH HHSUnited StatesG12MD007581PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT06263231A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)Background

Source ClinicalTrials.gov

Download CSV of trials

References178

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112370430Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals.Proc Natl Acad Sci U S A2002https://conductscience.org/library/papers/12370430PubMed
211085518Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.Cancer Res2000https://conductscience.org/library/papers/11085518PubMed
314576837Cisplatin: mode of cytotoxic action and molecular basis of resistance.Oncogene2003https://conductscience.org/library/papers/14576837PubMed
420935493Depletion of ribosomal protein L37 occurs in response to DNA damage and activates p53 through the L11/MDM2 pathway.Cell Cycle2010https://conductscience.org/library/papers/20935493PubMed
514751677Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats.Toxicology2004https://conductscience.org/library/papers/14751677PubMed
623404433Combined anticancer activity of osthole and cisplatin in NCI-H460 lung cancer cells in vitro.Exp Ther Med2013https://conductscience.org/library/papers/23404433PubMed
712835670Ovarian cancer: strategies for overcoming resistance to chemotherapy.Nat Rev Cancer2003https://conductscience.org/library/papers/12835670PubMed
87939763Paclitaxel (Taxol) for the treatment of head and neck cancer.Semin Oncol1994https://conductscience.org/library/papers/7939763PubMed
923239809Synergistic effect of olaparib with combination of cisplatin on PTEN-deficient lung cancer cells.Mol Cancer Res2013https://conductscience.org/library/papers/23239809PubMed
108375936Modulation of sensitivity of human ovarian cancer cells to cis-diamminedichloroplatinum(II) by 12-O-tetradecanoylphorbol-13-acetate and D,L-buthionine-S,R-sulphoximine.Int J Cancer1993https://conductscience.org/library/papers/8375936PubMed
1123494564Synergistic interaction of β-galactosyl-pyrrolidinyl diazeniumdiolate with cisplatin against three tumor cells.Arch Pharm Res2013https://conductscience.org/library/papers/23494564PubMed
128515048A histochemical approach to the mechanism of action of cisplatin and its analogues.J Histochem Cytochem1993https://conductscience.org/library/papers/8515048PubMed
1315986578
The activities of liver adenosine deaminase, xanthine oxidase, catalase, superoxide dismutase enzymes and the levels of malondialdehyde and nitric oxide after cisplatin toxicity in rats: protective effect of caffeic acid phenethyl ester.
Toxicol Ind Health2005https://conductscience.org/library/papers/15986578PubMed
142112183Fluorouracil, doxorubicin, cyclophosphamide, and cisplatin combination chemotherapy in advanced or recurrent salivary gland carcinoma.J Clin Oncol1990https://conductscience.org/library/papers/2112183PubMed
158521815Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor.EMBO J1995https://conductscience.org/library/papers/8521815PubMed
1612495431Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm.Biochem J2003https://conductscience.org/library/papers/12495431PubMed
171673965A phase II study of taxol in patients with malignant melanoma.Invest New Drugs1991https://conductscience.org/library/papers/1673965PubMed
1820811617Cellular responses to Cisplatin-induced DNA damage.J Nucleic Acids2010https://conductscience.org/library/papers/20811617PubMed
1919268559Caffeic acid phenethyl ester (CAPE) ameliorates cisplatin-induced hepatotoxicity in rabbit.Exp Toxicol Pathol2010https://conductscience.org/library/papers/19268559PubMed
2016847145Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin.Mol Pharmacol2006https://conductscience.org/library/papers/16847145PubMed

See all 178 referencesDownload CSV of references

Cited by2,520

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3,949 citations.

PMIDTitleJournalYearIn PapersSource
42985096Optimizing first-line therapy for advanced EGFR-mutated NSCLC: a patient-centered approach for low- and middle- income countries.Front Oncol2026https://conductscience.org/library/papers/42985096PubMed
42980935Gossypetin and luteolin, alone and with cisplatin, preferentially reduce MCF-7 breast cancer cell viability, whereas HeLa cervical cancer cells are refractory.Mol Biol Rep2026https://conductscience.org/library/papers/42980935PubMed
42967962Crosstalk between chemotherapeutics and tumor-associated macrophages (TAMs): implications for tumor response.J Cancer Res Clin Oncol2026https://conductscience.org/library/papers/42967962PubMed
42955194Cubosome integrated with polymeric carbon nitride and cisplatin: in vivo biodistribution and in vitro photodynamic therapy studies.Discov Nano2026https://conductscience.org/library/papers/42955194PubMed
42949705Label-free Raman spectroscopy for cancer therapy response: from methodological framework to clinical translation.Chem Soc Rev2026https://conductscience.org/library/papers/42949705PubMed
42948278Cancer Evolvability Determines Therapy Outcomes.Evol Appl2026https://conductscience.org/library/papers/42948278PubMed
42943362Nelfinavir Synergizes with Cisplatin and Promotes GSDME-Associated Lytic Cell Death in Platinum-Resistant Ovarian Cancer Cells.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42943362PubMed
42943233Biological Effects of Umbelliferone in MCF-7 Breast Cancer Cells: Integrated In Vitro and Computational Analyses.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42943233PubMed
42940183A Non-Linear Ototoxic Response to Cisplatin Is Associated with Autophagy and PTEN/PI3K/AKT Signaling in Cochlear Hair Cells and Spiral Ganglion Neurons.Biomedicines2026https://conductscience.org/library/papers/42940183PubMed
42938830Beyond Platinum Resistance: Reconsidering Platinum Sensitivity as a Dynamic Phenotype in Ovarian Cancer.Cancers (Basel)2026https://conductscience.org/library/papers/42938830PubMed
42932045Cannabidiol impairs tumor-associated behaviors and modulates apoptosis- and autophagy-related pathways in cisplatin-resistant head and neck squamous cell carcinoma.Med Oncol2026https://conductscience.org/library/papers/42932045PubMed
42927208SCML1 overexpression promotes DNA damage and improves the therapeutic efficacy of cisplatin for ovarian cancer.iScience2026https://conductscience.org/library/papers/42927208PubMed
42923595Potent Antineoplastic Activity against Breast Cancer in Vitro and in Vivo of a Chloro-Substituted Polyaromatic Platinum(II) Complex and Its Platinum(IV) Prodrug.ACS Omega2026https://conductscience.org/library/papers/42923595PubMed
42907850When drug repurposing backfires: antagonistic effects of ivermectin on cisplatin therapy in oral cancer.BMC Pharmacol Toxicol2026https://conductscience.org/library/papers/42907850PubMed
42895382Metal-dependent Structure, Solution Properties, and Redox-Mediated Anticancer Activity of Rhodium(III) and Iridium(III) Half-Sandwich Phenanthroline-Sulfonamide Complexes.Inorg Chem2026https://conductscience.org/library/papers/42895382PubMed
42883329Taking Charge Against the Silent Pandemic-Electrochemical Characterization of Drug Resistance.Molecules2026https://conductscience.org/library/papers/42883329PubMed
42877270Biodegradable ROS-Responsive TPCD Nanoparticles Mitigate Cisplatin-Induced Acute Kidney Injury via Synergistic Antioxidant and Immunomodulatory Actions.Int J Nanomedicine2026https://conductscience.org/library/papers/42877270PubMed
42867619The first formulation tailored for intraperitoneal delivery as a pressurised aerosol (PIPAC): doxorubicin-cisplatin as a fixed, ready-to-use drug combination.Drug Deliv Transl Res2026https://conductscience.org/library/papers/42867619PubMed
42866949Double-base deletions and signatures associated with platinum adducts in metastatic cancer.Nucleic Acids Res2026https://conductscience.org/library/papers/42866949PubMed
42831533Quercetin Attenuates Cisplatin-Induced Nephrotoxicity While Enhancing Antitumor Efficacy in Gastric Cancer via Cell Type-Specific Modulation of the ERK1/2 Pathway.J Biochem Mol Toxicol2026https://conductscience.org/library/papers/42831533PubMed

See all 2,520 cited byDownload CSV of cited by

Genes77

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
APAF1317PubTator's text mininghttps://conductscience.org/library/genes/317NCBI Gene
AQP2359PubTator's text mininghttps://conductscience.org/library/genes/359NCBI Gene
AQP5362PubTator's text mininghttps://conductscience.org/library/genes/362NCBI Gene
AQP9366PubTator's text mininghttps://conductscience.org/library/genes/366NCBI Gene
ATF4468PubTator's text mininghttps://conductscience.org/library/genes/468NCBI Gene
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
BAK1578PubTator's text mininghttps://conductscience.org/library/genes/578NCBI Gene
BAX581PubTator's text mininghttps://conductscience.org/library/genes/581NCBI Gene
BBC327113PubTator's text mininghttps://conductscience.org/library/genes/27113NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BCL2L1598PubTator's text mininghttps://conductscience.org/library/genes/598NCBI Gene
CALCR799PubTator's text mininghttps://conductscience.org/library/genes/799NCBI Gene
CASP8841PubTator's text mininghttps://conductscience.org/library/genes/841NCBI Gene
CASP9842PubTator's text mininghttps://conductscience.org/library/genes/842NCBI Gene
CAT847PubTator's text mininghttps://conductscience.org/library/genes/847NCBI Gene
CBLL2158506PubTator's text mininghttps://conductscience.org/library/genes/158506NCBI Gene
CDH1999PubTator's text mininghttps://conductscience.org/library/genes/999NCBI Gene
CDKN2C1031PubTator's text mininghttps://conductscience.org/library/genes/1031NCBI Gene

See all 77 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25058905

GET https://conductscience.org/api/papers/v1/25058905/references?page=2